Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewSK 575 is a potent PARP1 Degrader (PROTAC®; DC50 ≤ 6.72 nM, >99% PARP1 degradation at 10 nM). It comprises the PARP1/2 inhibitor Olaparib (Cat. No. 7579), joined by a linker to cereblon/cullin 4A ligand Thalidomide (Cat. No. 0652). SK 575 inhibits the growth of various cancer cell lines bearing BRCA1/2 mutations with IC50 values in the nanomolar range. It effectively reduces PARP1 protein levels in mouse SW620 tumor xenograft models. SK 575 dose-dependently potentiates the antitumor activity of Temozolomide (Cat. No. 2706) and Cisplatin (Cat. No. 2251) in vivo.
PARP antibodies validated for Simple Western™ (automated Western) instruments and Western Blot also available: Catalog # AF-600-NA and MAB8095.
PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.
M. Wt | 876.99 |
Formula | C47H53FN8O8 |
Storage | Store at -20°C |
Purity | ≥98% (HPLC) |
CAS Number | 2523016-96-6 |
PubChem ID | 162664494 |
InChI Key | HPBWDZVXFSTVMR-UHFFFAOYSA-N |
Smiles | FC1=CC=C(C=C1C(N2CCN(C(CCCCCCCCCCC(NCCNC3=C4C(N(C(C4=CC=C3)=O)C5CCC(NC5=O)=O)=O)=O)=O)CC2)=O)CC6=NNC(C7=CC=CC=C67)=O |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 87.7 | 100 |
The following data is based on the product molecular weight 876.99. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.14 mL | 5.7 mL | 11.4 mL |
5 mM | 0.23 mL | 1.14 mL | 2.28 mL |
10 mM | 0.11 mL | 0.57 mL | 1.14 mL |
50 mM | 0.02 mL | 0.11 mL | 0.23 mL |
References are publications that support the biological activity of the product.
Cao et al (2020) Discovery of SK-575 as a highly potent and efficacious Proteolysis-Targeting Chimera Degrader of PARP1 for treating cancers. J.Med.Chem. 63 11012 PMID: 32924477
If you know of a relevant reference for SK 575, please let us know.
Keywords: SK 575, SK 575 supplier, SK575, PARP1, Degraders, degrades, PROTAC, Olaparib, BRCA1/2, mutations, targeted, protein, degradation, TPD, Poly(ADP-ribose), Polymerase, Other, 7583, Tocris Bioscience
Citations are publications that use Tocris products.
Currently there are no citations for SK 575. Do you know of a great paper that uses SK 575 from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review SK 575 and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
This brochure highlights the tools and services available from Bio-Techne to support your Targeted Protein Degradation and Induced Proximity research, including:
Degraders (e.g. PROTACs) are bifunctional small molecules, that harness the Ubiquitin Proteasome System (UPS) to selectively degrade target proteins within cells. They consist of three covalently linked components: an E3 ubiquitin ligase ligand, a linker and a ligand for the target protein of interest. Authored in-house, this poster outlines the generation of a toolbox of building blocks for the development of Degraders. The characteristics and selection of each of these components are discussed. Presented at EFMC 2018, Ljubljana, Slovenia